Compare · ARYA vs MPLN
ARYA vs MPLN
Side-by-side comparison of ARYA Sciences Acquisition Corp III (ARYA) and MultiPlan Corporation (MPLN): market cap, price performance, sector, and recent activity on the wire.
Summary
- ARYA operates in Finance, while MPLN operates in Consumer Discretionary - the two are in different parts of the market.
- MPLN carries a market cap of $2.41B.
- MPLN has more recent analyst coverage (7 ratings vs 0 for ARYA).
- Company
- ARYA Sciences Acquisition Corp III
- MultiPlan Corporation
- Price
- $11.14+4.70%
- $23.17-1.43%
- Market cap
- -
- $2.41B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Business Services
- Business Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2020
- 2020
- News (4w)
- 0
- 0
- Recent ratings
- 0
- 7
MultiPlan Corporation
MultiPlan Corporation, together with its subsidiaries, provides data analytics and technology-enabled cost management, payment, and revenue integrity solutions to the healthcare industry in the United States. The company offers analytics-based services, which reduce medical costs through data-driven algorithms that detect claims over-charges and recommend or negotiate reimbursement; network-based services that reduce medical costs through contracted discounts with healthcare providers; and payment integrity services, which reduce medical costs by identifying and removing improper and unnecessary charges paid during the claim. It also provides health benefit plans, which features reference-based pricing and tools to engage health plan members and providers to make the use of benefits before and after care delivery. The company serves national insurance companies, Blue Cross and Blue Shield plans, provider-sponsored and independent health plans, third party administrators, insurance bill review companies, Taft-Hartley plans, and other entities that pay medical bills in the commercial healthcare, government, workers' compensation, and auto medical markets. MultiPlan Corporation was founded in 1980 and is headquartered in New York, New York.
Latest ARYA
- MarketBeat Ranks Stocks with Most Insider Buying in June 2021
- SEC Form SC 13D filed by ARYA Sciences Acquisition Corp III
- SEC Form D filed by ARYA Sciences Acquisition Corp III
- SEC Form SC 13D filed by ARYA Sciences Acquisition Corp III
- SEC Form SC 13D filed by ARYA Sciences Acquisition Corp III
- SEC Form SC 13D filed by ARYA Sciences Acquisition Corp III
- SEC Form 4: PERCEPTIVE ADVISORS LLC bought $55,070,983 worth of Common Stock (5,507,063 units at $10.00), increasing direct ownership by 1% to 497,038 units
- SEC Form 4: ALTMAN MICHAEL SETH converted 4,146,500 units into Common Stock
- ARYA Sciences Acquisition Corp III filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity Securities, Changes in Registrant’s Certifying Accountant, Financial Statements and Exhibits, Material Modification to Rights of Security Holders, Changes in Control of Registrant, Leadership Update, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Amendments to the Registrant’s Code of Ethics, or Waiver of a Provision of the Code of Ethics, Change in Shell Company Status, Regulation FD Discl
- Nautilus Biotechnology Debuts as Publicly Traded Company, Seeks to Deliver on the Untapped Potential of the Human Proteome
Latest MPLN
- ClearNote Health's Avantect® Pancreatic Cancer Test Now Available to Health Plan Members Accessing Claritev's National PPO Networks
- SEC Form 10-K filed by MultiPlan Corporation
- MultiPlan Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Claritev Reports Fourth Quarter and Full Year 2024 Results with Initial Guidance for Full Year 2025
- MultiPlan Corporation filed SEC Form 8-K: Other Events
- Claritev Provides Oracle Cloud HCM Customers with Actionable Insights for Healthcare Cost Optimization and Plan Design
- MultiPlan Corporation filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Regulation FD Disclosure, Financial Statements and Exhibits
- MultiPlan Enters New Era and Unveils New Brand, Claritev, Reflecting Company's Transformation and Mission to Support the Healthcare Continuum
- Amendment: SEC Form SCHEDULE 13G/A filed by MultiPlan Corporation
- MultiPlan Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Termination of a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits